SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is under pressure as traders react to the boards investigation into CEO Jensen Huangs admitted affair and allegations that the woman involved had ties to Chinese intelligence; the espionage claims remain unverified. The community is split between concerns about leadership and disclosure risks and views that the selloff is an overreaction and a buying opportunity.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is drawing attention ahead of its quarterly results after a sharp share-price decline, with traders debating whether the selloff signals weak results or is an opportunity to buy the dip. The Eli Lilly obesity-drug partnership is viewed as a growth opportunity, but some investors worry that branded medications could pressure margins; speculation about an earnings leak remains unverified.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics quarterly revenue beat and higher full-year outlook, driven by BRIUMVI growth, are the main focus; shares saw a sharp post-results dip and recovery, prompting debate over a sell the news reaction versus short-driven volatility. Traders are also watching for Phase 3 results on subcutaneous BRIUMVI as a next potential catalyst.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors HOPE-3 cardiac results receiving an American Heart Association research award has renewed attention to deramiocel ahead of the FDAs November 22 PDUFA decision for Duchenne muscular dystrophy. Traders are largely hopeful for approvalespecially on upper-limb function, which they distinguish from the advisory panels negative cardiac votewhile others stress that the outcome and any cardiac label remain uncertain.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

IWMs sharp rally is drawing attention as small caps outperform, with traders describing a possible low-volume short squeeze and rotation into the Russell 2000. Bulls are chasing calls and citing hopes for easing inflation, while skeptics question the moves strength given reported weak flows and limited volume.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candels SITC findings on immune activation and viral clearance, alongside its positive Phase 3 prostate-cancer results, are drawing attention as the company prepares a BLA for CAN-2409. Bulls see the data as supportive of the regulatory package, while skeptics question filing and manufacturing execution and warn of a possible sell-the-news reaction.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMDs rally is drawing support from Oppenheimers upgrade to Outperform on its AI and data-center outlook, alongside community discussion of Google Cloud using EPYC processors in its TPU infrastructure. Traders also see a possible rotation from Nvidia amid headlines about a board investigation into CEO Jensen Huang, while some caution that AMDs valuation and the sharp run-up leave room for volatility.

Axon Enterprise, Inc. engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services. The Software and Sensors segment includes devices, wearables, applications, cloud, and mobile products. The company was founded by Patrick W. Smith and Thomas P. Smith on September 7, 1993 and is headquartered in Scottsdale, AZ.

Axon Enterprise Inc

A quarterly earnings shortfall and reduced full-year revenue guidance, tied largely to federal Dedrone drone deployments being delayed, have driven a sharp selloff. Traders debate whether the decline overreacts to a timing issue or reflects high valuation and weaker near-term growth, with some buying the dip and others expecting further downside.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk shares are surging ahead of its Q3 results, with traders speculating about short covering and an possible earnings leak, though neither is confirmed. Bulls hope for a turnaround and stronger guidance, while skeptics warn that slowing ad growth and past post-earnings declines could lead to a reversal.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

SMCI is drawing attention as traders debate whether renewed scrutiny around Nvidia CEO Jensen Huang and alleged China-related chip diversions is weighing on the stock by association; some argue the concerns are speculative or unrelated to SMCI. The debate is sharpened by the stocks weak performance despite recent strong results and raised guidance, with bulls pointing to its valuation and bears citing governance, cash flow, and margin risks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Envue Medical (FEED) Shares Fall 23% After Hours: Here's What Is Going On

ENvue Medical shares fall after Nasdaq decision as FEED prepares to trade on OTC Markets.read more...

12 Health Care Stocks Moving In Wednesday's After-Market Session

Gainers

ENvue Medical (NASDAQ:FEED) shares rose 49.1% to $0.61 during Wednesday's after-market session. The market value of their outstanding shares is at $2.4 million.
Omeros (NASDAQ:OMER) stock moved upwards byread more...

Envue Medical Expands AI Navigation Platform With Robotic Prototype

ENvue Medical demonstrated its ENvue Drive prototype, combining AI, real-time navigation and robotic assistance for feeding tube placement.read more...

EXCLUSIVE: ENvue Medical Says Health System Renewal Extends Platform Adoption Through 2028

ENvue Medical secured a three-year renewal with a 12-hospital health system, extending its feeding tube platform use through 2028.read more...

EXCLUSIVE: ENvue Medical Locks In Multi-Year Access To Large US Nonprofit Hospital System Through 2028

ENvue Medical renewed a three-year purchasing agreement covering 90-plus hospitals across 17 states through 2028.read more...

What's Going On With ENvue Medical Stock On Thursday?

ENvue Medical shares slip premarket on Thursday after rally as Detroit hospital purchase lifts adoption to 39 sites.read more...

What's Behind The Jump In ENvue Medical Stock Today?

Shares of ENvue Medical, Inc. (NASDAQ: FEED) are surging on Tuesday after the company disclosed a new hospital system win that lifts its U.S. footprint to 39 hospitals.read more...

Small Caps Push Big Narratives, as Innovation Drives

It’s a relatively quiet session across broader markets, but beneath the surface, a wave of company-specific developments will keep traders engaged. $KBLB, $RAYA, $FEED, $ELAB, $YMT, $PAVS, $UGRO

Insider Buying: Nanovibronix (NASDAQ:FEED) Major Shareholder Purchases 240,000 Shares of Stock

Nanovibronix, Inc. (NASDAQ:FEED - Get Free Report) major shareholder Christian Michael Glibert purchased 240,000 shares of the firm's stock in a transaction dated Wednesday, January 14th. The stock...

Why Is FEED Stock Soaring Over 130% Today?

Equity

ENvue Medical announced a distribution agreement with enteral feeding supplies provider U-Deliver. 


ENvue Medical, Inc. (NASDAQ: FEED) is a medical technology company advancing two platforms: ENvue Navigation, an electromagnetic system guiding non-invasive feeding tube placement, and NanoVibronix, acoustic wave devices that treat pain and disrupt bacterial infections. Serving both clinical and home care settings, with R&D in Tel Aviv, Israel and headquarters in Tyler, Texas.

ENvue Medical Inc.

Bullish Sentiment

<ul class="summary-bullets"><li>The agreement is aimed at distributing Texas-based ENvue’s recently launched over-the-counter reusable ENFit Syringes product line nationwide.&nbsp;</li><li>The syringes were launched earlier this month and are designed to meet both feeding and medication delivery clinical needs.&nbsp;</li><li>The new deal would utilize U-Deliver’s digital and wholesale channels to broaden access to the syringes launched earlier this month.&nbsp; &nbsp;</li></ul>Shares of ENvue Medical, Inc. (FEED) jumped 138% on Wednesday after the company announced a distribution agreement with enteral feeding supplies provider U-Deliver.The <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2026/01/28/3227664/0/en/ENvue-Medical-Signs-Strategic-Partnership-Agreement-with-U-Deliver-for-U-S-Distribution-of-Over-the-Counter-Reusable-ENFit-Syringe-Line.html">agreement</a> is aimed at distributing Texas-based ENvue’s recently launched over-the-counter reusable ENFit Syringes product line nationwide through non-acute care channels. The deal would utilize U-Deliver’s digital and wholesale channels to broaden access to the syringes launched earlier this month.<h2 class="st-heading-2">About ENVue Syringes</h2>ENvue’s ENFit Syringes are currently available through U-Deliver’s website, Amazon storefront, and wholesale channels in 2.5 mL, 5 mL, 10 mL, and 60 mL sizes. These syringes, designed for reuse for up to seven days or 20 uses, do not require a prescription. They are also designed to meet both feeding and medication delivery clinical needs.ENVue was formerly called NanoVibronix. The company switched names to reflect its focus on the ENvue feeding-tube placement system, which it gained access to with the acquisition of privately-held ENvue Medical Holdings Corp in February 2025.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around FEED rose from ‘bearish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume increased from ‘low’ to ‘extremely high’ levels.A Stocktwits user said that they sold their shares in the company for a 20% profit.<stembedurl>https://www.stocktwits.com/NathanN23/message/643168472</stembedurl>Another user, however, highlighted the company’s “insanely low” market cap, adding that it is less than someone's net worth.<stembedurl>https://www.stocktwits.com/Shorting_BTC_Since_2009/message/643160653</stembedurl>Yet another user predicted upcoming dilution efforts.<stembedurl>https://www.stocktwits.com/Biotoneten/message/643159817</stembedurl><a href="https://stocktwits.com/symbol/FEED">FEED stock</a> has lost about 94% over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/cvna-shares-in-spotlight-after-gotham-city-research-highlights-red-flags/cmygaQtR400">CVNA Shares In Spotlight After Gotham City Research Highlights Red Flags — What Does The Street Think?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

ENvue Medical announced a distribution agreement with enteral feeding supplies provider U-Deliver. 

Vanguard Extended Market ETF

Buying the dip

Selling or trimming

Holding

Waiting for the investigation results to decide

Nvidia ($NVDA) is down about 4% after its board opened an investigation into CEO Jensen Huang. What are you doing with the stock?

Stocktwits

) is down about 4% after its board opened an investigation into CEO Jensen Huang. What are you doing with the stock?

Current Price	$0.3052
Prev Close	$0.3421
Open	$0.2601
Dividend Yield	0.00%
50-Day Moving Average	$0.4096
Beta	0.00
Avg. Volume	14,336.45
PE Ratio	0.00

52-Week High	$0.99
52-Week Low	$0.121
Market Capitalization	$315,993.00
EPS (Annual)	-$320.27
Price to Book	0.01
Revenue Per Employee	$182,357.14

Feed

News

Sentiment

Fundamentals

Info

FEED Fundamentals